Editor’s Note: Sharon Presnell discussed the use of bioprinting and 3D tissue to improve predictability in preclinical drug discovery this week at the BIO 2014 convention in San Diego. —BVB The human race consists of a large population of genetically diverse organisms. This inherent diversity is compounded daily by the individualistic way we go about … Continue reading “BIO 2014: Innovations in 3-D Tissue for Disease and Drug Discovery”
Author: Sharon C. Presnell
Sharon C. Presnell is the chief technology officer at Organovo, a San Diego-based company developing proprietary 3-D bioprinting technology for medical research and therapeutic applications. She has spent over 18 years overseeing product-focused R&D. Her work in liver and prostate biology and carcinogenesis produced new cell- and tissue-based technologies that were licensed for industrial applications.